iOnco
Back to Therapy Library
🥑

Ketogenic Diet as Cancer Therapy

Metabolic Therapymoderate evidenceHome Possible
Oral

The Ketogenic Diet (KD) as cancer therapy exploits the Warburg effect — cancer cells' near-total dependence on glucose for energy. By restricting carbohydrates to <20–50 g/day, blood glucose and insulin drop dramatically, starving glucose-dependent tumours. Normal cells adapt to use ketones (from fat breakdown) as fuel; most cancer cells cannot. Pioneered by Dr Thomas Seyfried at Boston College, the metabolic theory of cancer suggests KD may be the most evidence-based dietary anti-cancer intervention. Multiple clinical trials are ongoing.

Mechanism of Action

Lowering blood glucose drops insulin and IGF-1 (growth factors that stimulate cancer). Ketones (beta-hydroxybutyrate, acetoacetate) are used efficiently by normal brain cells but most cancer cells lack the metabolic flexibility to switch to ketone oxidation. KD also reduces inflammation (NF-κB inhibition by BHB), reduces cancer cell proliferation signalling (PI3K/Akt/mTOR pathway), and when combined with caloric restriction, acts synergistically with conventional cancer treatments.

🎗️

Cancer Types Studied

BrainPancreaticBreastColonProstateAll Cancers

Protocols & Dosing

Classic Therapeutic KD (Cancer)

Fat:protein+carb ratio of 3:1 or 4:1 by grams. Total carbs <20 g/day. Target blood glucose: 60–80 mg/dL. Target blood ketones: 2–7 mmol/L (measured with blood ketone meter). Supervised by dietitian.

Modified Atkins / Low-Carb Approach

Less restrictive: <50 g carbs daily, moderate protein, high fat. Achieves moderate ketosis (0.5–2 mmol/L). Easier to sustain long-term. Recommended for most patients as starting point.

Water Fasting + KD Cycling

24–72 hour water fasts (physician-supervised) before chemotherapy sessions (shown to protect normal cells while sensitising cancer). Followed by ketogenic maintenance between cycles.

NIH / PubMed Research

Links open on PubMed (National Library of Medicine). Research is ongoing — results may not reflect clinical use.

Cautions & Contraindications

  • Must maintain adequate protein to prevent muscle wasting (cancer cachexia risk)
  • Requires close monitoring of glucose, ketones, electrolytes, and liver enzymes
  • Some cancers metabolise ketones (certain brain tumours) — discuss with oncologist
  • Difficult to sustain long-term without dietitian support
  • Electrolyte supplementation (sodium, potassium, magnesium) required
  • Contraindicated in fatty acid oxidation disorders and some metabolic conditions

Informational only. Not medical advice. Consult your oncologist before starting any alternative or integrative therapy.